Yujing Xin

Immune checkpoint inhibitors and anti-vascular endothelial growth factor antibody/tyrosine kinase inhibitors with or without transarterial chemoembolization as first-line treatment for advanced hepatocellular carcinoma (CHANCE2201): a target trial emulation study

Zhi‐Cheng Jin, Jian-Jia Chen, Xiaoli Zhu et al. · EClinicalMedicine · 2024 · 119 citations · Full text

Medicine, Immune Checkpoint Inhibitors, Immunology +9

Efficacy and safety of lenvatinib plus PD-1 inhibitor with or without transarterial chemoembolization in unresectable hepatocellular carcinoma

Yujing Xin, Xinyuan Zhang, Ning Liu et al. · Hepatology International · 2023 · 51 citations

Hepatology, Hepatocellular Carcinoma, Medicine +10

Late recurrence of hepatocellular carcinoma after radiofrequency ablation: a multicenter study of risk factors, patterns, and survival

Yi Yang, Yi Chen, Feng Ye et al. · European Radiology · 2020 · 50 citations

Surgical Oncology, Hepatology, Radiofrequency Ablation +9

Efficacy and safety of atezolizumab plus bevacizumab combined with hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma

Yujing Xin, Fei Cao, Hongcai Yang et al. · Frontiers in Immunology · 2022 · 43 citations · Full text

A Systemic Inflammation Response Index (SIRI)-Based Nomogram for Predicting the Recurrence of Early Stage Hepatocellular Carcinoma After Radiofrequency Ablation

Yujing Xin, Xinyuan Zhang, Ying Li et al. · CardioVascular and Interventional Radiology · 2021 · 26 citations

Hepatology, Radiofrequency Ablation, Medicine +10